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The aim of this paper is to report a patient with late-onset myoclonic epilepsy in Down’s syndrome (LOMEDS) as a differential
diagnosis of adult-onset progressive myoclonic epilepsies.
A 55-year-old male with Down’s syndrome (DS) is described who developed progressively frequent myoclonus and gener-
alized myoclonic–tonic seizures (GMTSs) at the age of 52. EEG recordings demonstrated background slowing and generalized
polyspike-wave discharges occasionally associated with myoclonic jerks, leading to the classification of primary generalized
epileptic myoclonus. Descriptions of late-onset epilepsy in DS patients are rare. However, a review of the pertinent literature
revealed at least two other cases of elderly DS patients developing progressive myoclonic epilepsy after the onset of dementia.
We suggest that late-onset myoclonic epilepsy in Down’s syndrome as characterized here should be considered in the differen-
tial diagnosis of adult-onset myoclonic epilepsies. LOMEDS apparently shares features with myoclonic epilepsy in Alzheimer’s
disease (AD) and Unverricht–Lundborg disease (ULD) caused by a mutation on chromosome 21. Since life expectation of DS
patients has markedly increased, LOMEDS may be more frequent than currently acknowledged.
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INTRODUCTION
Epilepsy in Down’s syndrome (DS) has been fre-
quently observed and its prevalence increases with
age, reaching 46% in patients over 50 years compared
to approximately 9% in patients over 18 years1–3. A
bimodal onset of seizures in DS with a peak incidence
during early childhood and in middle age has been de-
scribed by several authors4, 5. A triphasic distribution
of seizure onset has also been suggested, i.e. during
infancy, early adulthood and a particular epilepsy in
patients over 50 years1, 4. As longevity of subjects with
DS is increasing, epilepsy with late onset will be more
frequently encountered in the future6.
Thus far, descriptions of epilepsy with onset during
or after the fifth decade in DS have been rare, but in-
clude at least two individuals featuring myoclonic as
well as generalized tonic–clonic seizures (GTCSs)7, 8.
Here we report a further case of late-onset progressive
myoclonic epilepsy in DS and discuss the pertinent lit-
erature.
CASE REPORT
A 55-year-old male patient with DS was admitted
to our hospital with the first occurrence of a gener-
alized myoclonic–tonic seizure (GMTS). Apart from
increased muscle tone and gait disturbance, physical
examination did not reveal any significant neurolog-
ical abnormalities. Due to mental retardation, mini-
mental-state examination yielded a score of one point
while a CT scan revealed cortical atrophy. MRI exam-
ination was not possible due to non-compliance of the
patient. The clinical diagnosis of DS was confirmed by
cytogenetic analysis.
Approximately 3 years before admission, myoclonic
jerks, particularly of the upper extremities, had started.
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Fig. 1: EEG of the patient showing generalized continuous slowing, generalized intermittent rhythmic slowing and polyspike-wave
complexes (a and b). (b) shows a polyspike-wave complex followed by a myoclonic jerk about 185 ms after onset of the polyspike
component as visible in the ECG lead (arrow) and noted by the technician (marker line).
These usually occurred in the morning and could
be improved by administration of sodium valproate
(1800 mg per day). Reduction of this compound be-
cause of daytime somnolence temporally coincided
with the occurrence of the first GMTS as described
by a witness. Due to aggressive behaviour during the
addition of lamotrigine, the medical regimen was not
closely followed, and additional GMTSs occurred. On
a low dose of sodium valproate (900 mg per day),
GMTSs were finally controlled but myoclonic jerks
increased over the subsequent months. Therefore, top-
iramate (100 mg per day) was introduced, leading to
significant and sustained improvement.
EEG recordings, when sodium valproate serum lev-
els were below detection threshold, showed gener-
alized continuous slowing, generalized intermittent
rhythmic slowing as well as generalized polyspike-
wave complexes (Fig. 1a). The latter were occasion-
ally associated with generalized myoclonic jerks oc-
curring 180–250 ms after the onset of the polyspike
component (Fig. 1b). No epileptiform discharges
were recorded on monotherapy with sodium valproate
6 months later.
DISCUSSION
Epilepsy in DS characterized by seizure onset after the
fourth decade, myoclonic jerks, occasional GTCSs,
and progressive dementia has previously been de-
scribed in two cases7, 8. In addition, epileptic seizures
and myoclonus had already been observed in nine de-
mented elderly DS patients9. In a prevalence study of
epilepsy in DS, three patients with onset of epilepsy
after the age of 45 were identified. Interestingly, each
of these individuals was clinically characterized by de-
mentia, myoclonus and GTCSs10. EEG documenta-
tion, however, was only provided in the two patients
mentioned above7, 8. Our patient presented with my-
oclonic jerks in the morning and occasional GMTSs
with onset after the age of 50. Progressive demen-
tia could not be evaluated due to severe mental retar-
dation. Although, including our case, 15 elderly DS
patients could be identified in the literature with proba-
ble myoclonic epilepsy, late-onset myoclonic epilepsy
in Down’s syndrome (LOMEDS) is currently not in-
cluded among the possible causes of epileptic my-
oclonus11. We therefore propose that LOMEDS, as
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characterized above, should be included in the differ-
ential diagnosis of adult-onset myoclonic epilepsies.
Generalized epilepsy was proven by demonstration
of generalized epileptiform discharges in all cases with
EEG documentation. Furthermore, the time-locked as-
sociation of polyspike-wave complexes preceding the
myoclonus in our patient and in the patient reported
by Genton and Paglia7 allows the classification of pri-
mary generalized epileptic myoclonus12. LOMEDS
may be successfully controlled by the administration
of valproate and topiramate. However, the latter has to
be used with particular caution in DS patients since
topiramate may induce further deterioration of cogni-
tion. Piracetam and levetiracetam are other treatment
options for myoclonic epilepsies.
Myoclonus is also found in the majority of
Alzheimer’s disease (AD) patients with epilepsy13.
Since accumulation of beta-amyloid has been found
in both individuals affected with AD and ageing DS
patients with dementia14, a common pathogenesis
of dementia and myoclonic epilepsy in elderly DS
patients and patients with AD appears likely15. Pos-
sibly, LOMEDS purely indicates comorbidity with
AD in patients with DS. There are also similarities
between LOMEDS and Unverricht–Lundborg (ULD),
such as generalized epileptiform discharges and gen-
eralized slowing in the EEG. However, there is no
clear evidence of a causal relationship between these
two conditions16.
CONCLUSIONS
In summary, we suggest that late-onset epilepsy in
elderly, demented DS patients characterized by my-
oclonus, occasional GTCSs or GMTSs, generalized
epileptiform discharges in EEG, and slow progres-
sion may represent a distinct epilepsy syndrome
(LOMEDS). Myoclonus in this syndrome can be clas-
sified as primary generalized epileptic myoclonus.
More subjects suffering from late-onset epilepsy in
DS have to be investigated to allow for a more detailed
description of this syndrome. It will then be possible
to judge whether LOMEDS is a distinct syndrome
or a mere association of DS and AD with myoclonic
seizures.
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